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Abstract: The unexpected substitution of fluorine atoms and phenoxy groups attached to 
quinoxaline or benzofuroxan rings is described. The synthesis of 2-benzyl- and 2-phenoxy-
3-methylquinoxaline 1,4-di-N-oxide derivatives was based on the classical Beirut reaction. 
The tendency of fluorine atoms linked to quinoxaline or benzofuroxan rings to be replaced 
by a methoxy group when dissolved in an ammonia saturated solution of methanol was 
clearly demonstrated. In addition, 2-phenoxyquinoxaline 1,4-di-N-oxide derivatives 
became 2-aminoquinoxaline 1,4-di-N-oxide derivatives in the presence of gaseous 
ammonia.  
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Introduction 
 
Quinoxaline and quinoxaline-1,4-di-N-oxide are heterocycles that are frequently used in the 
synthesis of biologically active compounds [1-4]. The quinoxaline moiety is described as a bioisoster 
Molecules 2008, 13  87 
 
 
of the quinoline, naphthyl, benzothienyl and other aromatic rings [5], and the widespread activity of 
quinoxaline-1,4-di-N-oxide derivatives can be associated with the generation of free radicals [6]. In 
our continuing efforts to find quinoxaline-1,4-di-N-oxide derivatives with antimycobacterial [7-9] 
antiprotozoal [10-16] and anti-cancer activity [17, 18], a series of 2-benzyl-3-methylquinoxaline 1,4-
di-N-oxide derivatives was proposed. With regards to work carried out by our research team, this 
series involves the analogues of 2-benzoyl-3-methylquinoxaline 1,4-di-N-oxide derivatives in which 
the carbonyl group has been reduced [7]. In addition, with regards to Carta’s paper [19], this series, 
together with a series of 2-phenoxy-3-methylquinoxaline 1,4-di-N-oxide derivatives, could complete 
the bioisosterism replacements based on Grimm’s Hydride Displacement Law (Scheme 1). This law 
states that the addition of a hydrogen atom with a pair of electrons (i.e. hydride) to an atom belonging 
to groups 4A, 5A, 6A, 7A on the Periodic Table, produces an isoelectronic pseudoatom, showing the 
same physical properties as those present in the column immediately behind the initial atom on the 
Periodic Table of the Elements [5]. The aim of this work was to obtain 2-benzyl- and 2-phenoxy-3-
methylquinoxaline 1,4-di-N-oxide derivatives as potential antitubercular drug candidates. 
 
Scheme 1. Design of new quinoxaline-1,4-di-N-oxide derivatives with antimycobacterial activity. 
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Results and Discussion 
 
In a continuing effort to obtain new antitubercular drug candidates, the synthesis of 2-benzyl- and 
2-phenoxy-3-methylquinoxaline 1,4-di-N-oxide derivatives was proposed. The synthesis of each of 
these compounds was based on the classical Beirut reaction and, in this case, methanol and gaseous 
ammonia were chosen as reaction solvent and catalyst, respectively. 
After workup, all the compounds obtained were chemically characterized by thin layer 
chromatography (TLC), infrared (IR) and nuclear magnetic resonance (1H-NMR) spectra, as well as by 
elemental microanalysis. From these analyses, it was realised that the reaction with phenoxyacetone 
had failed to give the functionalized 2-phenoxy derivatives; surprisingly, this reaction gave other 
quinoxaline 1,4-di-N-oxide derivatives 10-12, with an amino group, instead of the phenoxy moiety, 
linked to C2 of the quinoxaline ring (analytical data in the Experimental section). It is well known that 
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the phenoxy scaffold is a good leaving group and that the ammonia gas is a potent base; the curious 
part is that first the quinoxaline is formed and later, the substitution occurs (the events could not have 
occurred in any other way due to the products obtained) (Scheme 2).  
 
Scheme 2. Possible mechanism of reaction for 2-amino-3-methylquinoxaline 
1,4-di-N-oxide derivatives. 
N
O
N
+
O
R7
R6
O
O
N
HH
H
O
N
NH4+
O
N
N
+
O
O
N
+
NH
OR7
R6
N
+
O
O
N
+
NH2
OR7
R6
N
+
N
+
R7
R6
O
O
O
N
HH
H
O
N
+
N
+
R7
R6
O
O
NH2
+
+
..
exc.
-
-
:
δ+..
 
 
The experimental conditions (reaction solvent and catalyst) were explored with the aim of obtaining 
the target compounds. In an attempt to synthesize the 2-phenoxy derivatives, the catalyst and the 
solvent were substituted by piperidine and dichloromethane, respectively. In this case, the 2-phenoxy-
3-methylquinoxaline 1,4-di-N-oxide (13) was obtained (Scheme 3). 
 
Scheme 3. Synthesis of 2-benzyl- and 2-phenoxy-3-methylquinoxaline 1,4-di-N-oxide derivatives. 
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The formation of isomeric quinoxaline 1,4-di-N-oxide was observed in the case of monosubstituted 
benzofuroxans. According to previous reports [20], we have observed that 7-substituted quinoxaline 
1,4-di-N-oxide derivatives prevailed over the 6-isomer, or in the case of the methoxy substituent, only 
the 7-isomer was formed (NOESY data, not shown). In practice, the workup and purification permitted 
isolation of the 7-isomer [21]. 
On the other hand, it was also observed that the reaction of difluorobenzofuroxan with 
benzylacetone in methanol failed to give 2-benzyl-6,7-difluoro-3-methylquinoxaline 1,4-di-N-oxide 
(7); the 1H-NMR spectra of the obtained compound showed the presence of a methoxy group in the 
structure and that it corresponded to a 6,7-disubstituted quinoxaline; we consequently thought that, 
under these conditions, the fluorine atom in position 6 was being substituted by a methoxy group from 
the solvent (compound 6). Such a displacement of the fluorine atom in position 6 has been observed on 
other occasions [22]. In an attempt to obtain the 6,7-difluoro derivative, the solvent was changed but 
keeping the remainder of the reaction conditions constant. In this case, using dichloromethane as 
reaction solvent, 2-benzyl-6,7-difluoro-3-methyl-quinoxaline 1,4-di-N-oxide (7) was obtained 
(Scheme 4).  
Scheme 4. Synthesis of 2-benzyl-7-fluoro-6-methoxy- and 2-benzyl-6,7-difluoro-3-
methylquinoxaline 1,4-dioxides. 
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Finally, we observed another curiosity arising from the use of fluorinated compounds. When we 
attempted to prepare R7(R6)-fluorobenzofuroxan by oxidation of the corresponding fluoronitroaniline, 
as previously described [23], the compound obtained was actually R7(R6)-methoxybenzofuroxan. 
Once again, methanol was present in the reaction as solvent. Therefore R7(R6)-fluorobenzofuroxan 
was prepared by thermal decomposition as reported [22, 23, 24].  
 
Scheme 5. Synthesis of 5(6)-fluorobenzofuroxan from the corresponding o-nitroaniline. 
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Conclusions 
 
Summarizing, this work clearly demonstrates the tendency of fluorine atoms linked to quinoxaline 
or benzofuroxan rings to leave their positions and be replaced by a methoxy group when dissolving in 
an ammonia saturated solution of methanol. In addition, the 2-phenoxyquinoxaline 1,4-di-N-oxide 
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derivatives, in the presence of gaseous ammonia, become 2-aminoquinoxaline 1,4-di-N-oxide 
derivatives.  
Experimental  
 
General 
 
All the synthesized compounds were chemically characterized by thin layer chromatography (TLC), 
infrared (IR), nuclear magnetic resonance (1H-NMR), mass spectra (MS) and elemental microanalysis 
(CHN). Alugram SIL G/UV254 (Layer: 0.2 mm) (Macherey-Nagel GmbH & Co. KG., Düren, 
Germany) was used for TLC and Silica gel 60 (0.040-0.063 mm, Merck) for Flash Column 
Chromatography. The 1H-NMR spectra were recorded on a Bruker 400 Ultrashield instrument (400 
MHz), using TMS as the internal standard and with DMSO-d6 or CDCl3 as the solvents; the chemical 
shifts are reported in ppm (δ) and coupling constants (J) values are given in Hertz (Hz). Signal 
multiplicities are represented by: s (singlet), d (doublet), t (triplet), q (quadruplet), dd (double doublet) 
and m (multiplet). The IR spectra were recorded on a Nicolet Nexus FTIR (Thermo, Madison, USA) in 
KBr pellets. Mass spectra were measured on a MSD/DS 5973N mod. G2577A mass spectrometer 
(Agilent Technologies, Waldbronn, Germany) equipped with a direct insertion probe (DIP) and the 
ionization method was electron impact (EI, 70 eV). Elemental microanalyses were obtained on an 
CHN-900 Elemental Analyzer (Leco, Tres Cantos, Spain) from vacuum-dried samples. The analytical 
results for C, H, and N, were within ± 0.4 of the theoretical values. Chemicals were purchased from 
Panreac Química S.A. (Barcelona, Spain), Sigma-Aldrich Química, S.A. (Alcobendas, Spain), Acros 
Organics (Janssen Pharmaceuticalaan, Geel, Belgium) and Lancaster (Bischheim-Strasbourg, France). 
 
General synthesis of 2-benzyl-3-methylquinoxaline 1,4-di-N-oxide derivatives 1-9 [11, 19] 
 
Equimolar amounts (3.0–10.0 mmol) of the appropriate benzofuroxan and benzylacetone were 
added to methanol (20 mL) [or dichloromethane (20 mL) for the 6,7-difluoro derivative]. Gaseous 
ammonia gas was bubbled for 10 minutes through the mixture, which was then stirred at room 
temperature for 4 hours. After evaporating to dryness under reduced pressure, a crude solid was 
obtained, which was then washed by adding diethyl ether and purified by recrystallization from a 
mixture of methanol/dichloromethane. 
 
2-Benzyl-3-methylquinoxaline 1,4-di-N-oxide (1). IR ν/cm-1: 1320, 1074, 713; 1H-NMR (CDCl3) 
δ/ppm: 2.76 (s, 3H, C3-CH3), 4.62 (s, 2H, C2-CH2-Ph), 7.29 (m, 5H, CH2-C6H5), 7.85 (m, 2H, 
H6+H7), 8.67 (m, 2H, H5+H8). 
 
2-Benzyl-7-fluoro-3-methylquinoxaline 1,4-di-N-oxide (2). IR ν/cm-1: 1321, 1077, 712; 1H-NMR 
(CDCl3) δ/ppm: 2.75 (s, 3H, C3-CH3), 4.60 (s, 2H, C2-CH2-Ph), 7.30 (m, 5H, CH2-C6H5), 7.58 (ddd, 
J=2.74, 7.39, 9.52 Hz, 1H, H6), 8.33 (dd, J= 2.69, 8.75 Hz, 1H, H8), 8.68 (dd, J=5.10, 9.48 Hz, 1H, 
H5). 
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2-Benzyl-7-chloro-3-methylquinoxaline 1,4-di-N-oxide (3). IR ν/cm-1: 1323, 1076, 713; 1H-NMR 
(CDCl3) δ/ppm: 2.74 (s, 3H, C3-CH3), 4.59 (s, 2H, C2-CH2-Ph), 7.30 (m, 5H, CH2-C6H5), 7.77 (dd, 
J=2.21, 9.17 Hz, 1H, H6), 8.60 (d, J=9.16 Hz, 1H, H5), 8.69 (d, J=2.20 Hz, 1H, H8). 
2-Benzyl-3,7-dimethylquinoxaline 1,4-di-N-oxide (4). IR ν/cm-1: 1322, 1080, 704; 1H-NMR (CDCl3) 
δ/ppm: 2.63 (s, 3H, C7-CH3), 2.77 (s, 3H, C3-CH3), 4.62 (s, 2H, C2-CH2-Ph), 7.30 (m, 5H, CH2-
C6H5), 7.85 (m, 2H, H6+H7), 8.67 (m, 2H, H5+H8), 7.68 (d, J=8.91 Hz, 1H, H6), 8.47 (s, 1H, H8), 8.54 
(d, J=8.78 Hz, 1H, H5). 
 
2-Benzyl-7-methoxy-3-methylquinoxaline 1,4-di-N-oxide (5). IR ν/cm-1: 1322, 1071, 707; 1H-NMR 
(CDCl3). δ/ppm: 2.74 (s, 3H, C3-CH3), 4.02 (s, 3H, C7-OCH3), 4.61 (s, 2H, C2-CH2-Ph), 7.25 (m, 5H, 
CH2-C6H5), 7.43 (dd, J=2.72, 9.49 Hz, 1H, H6), 7.98 (d, J=2.71 Hz, 1H, H8), 8.54 (d, J=9.46 Hz, 1H, 
H5). 
 
2-Benzyl-7-fluoro-6-methoxy-3-methylquinoxaline 1,4-di-N-oxide (6). IR ν/cm-1: 1321, 1078, 703; 1H-
NMR (CDCl3) δ/ppm: 2.75 (s, 3H, C3-CH3), 4.11 (s, 3H, C6-OCH3), 4.58 (s, 2H, C2-CH2-Ph), 7.29 
(m, 5H, CH2-C6H5), 8.07 (d, J=7.85 Hz, 1H, H5), 8.33 (d, J=10.72 Hz, 1H, H8). 
 
2-Benzyl-6,7-difluoro-3-methylquinoxaline 1,4-di-N-oxide (7). IR ν/cm-1: 1322, 1080; 1H-NMR 
(CDCl3) δ/ppm: 2.75 (s, 3H, C3-CH3), 4.58 (s, 2H, C2-CH2-Ph), 7.30 (m, 5H, CH2-C6H5), 8.47 (dd, 
J=9.28, 16.80 Hz, 2H, H5+H8). 
 
2-Benzyl-6,7-dichloro-3-methylquinoxaline 1,4-di-N-oxide (8). IR ν/cm-1: 1320, 1074, 713; 1H-NMR 
(CDCl3) δ/ppm: 2.74 (s, 3H, C3-CH3), 4.56 (s, 2H, C2-CH2-Ph), 7.33 (m, 5H, CH2-C6H5), 8.75 (s, 1H, 
H5); 8.78 (s, 1H, H8). 
 
2-Benzyl-3,6,7-trimethylquinoxaline 1,4-di-N-oxide (9). IR ν/cm-1: 1327, 1082, 706; 1H-NMR (CDCl3) 
δ/ppm: 2.52 (s, 6H, C6-CH3+C7-CH3), 2.73 (s, 3H, C3-CH3), 4.59 (s, 2H, C2-CH2-Ph), 7.27 (m, 5H, 
CH2-C6H5), 8.39 (s, 1H, H8), 8.42 (s, 1H, H5). 
 
General synthesis of 2-amino-3-methylquinoxaline 1,4-di-N-oxide derivatives 10-12.  
 
Equimolar amounts (3.0–10.0 mmol) of the appropriate benzofuroxan and phenoxyacetone were 
added to methanol (20 mL). Gaseous ammonia was bubbled through the mixture for 10 minutes and 
then it was stirred at room temperature for 4 hours. After evaporating to dryness under reduced 
pressure, a crude solid was obtained. This was then washed by adding diethyl ether and purified by 
recrystallization from a mixture of methanol/dichloromethane. 
 
2-Amino-3-methylquinoxaline 1,4-di-N-oxide (10). IR ν/cm-1: 3400, 3290, 1616, 1329; 1H-NMR 
(DMSO-d6) δ/ppm: 2.57 (s, 3H, C3-CH3), 7.61 (m, 3H, NH2+H6), 7.81 (t, J=7.78 Hz, 1H, H7), 8.31 
(dd, J=0.72, 8.53 Hz, 1H, H5), 8.37 (dd, J=0.73, 8.53 Hz, 1H, H8). 
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2-Amino-7-chloro-3-methylquinoxaline 1,4-di-N-oxide (11). IR ν/cm-1: 3385, 3262, 1623, 1327; 1H-
NMR (DMSO-d6). δ/ppm: 2.55 (s, 3H, C3-CH3), 7.61 (dd, J=1.58, 9.07 Hz, 1H, H6), 7.77 (s, 2H, 
NH2), 8.26 (d, J=2.23 Hz, 1H, H8), 8.36 (d, J=9.12 Hz, 1H, H5). 
 
2-Amino-6,7-dichloro-3-methylquinoxaline 1,4-di-N-oxide (12). IR ν/cm-1: 3416, 3299, 1617, 1325; 
1H-NMR (DMSO-d6). δ/ppm: 2.55 (s, 3H, C3-CH3), 7.86 (s, 2H, NH2), 8.42 (s, 1H, H5), 8.50 (s, 1H, 
H8) 
 
Synthesis of 3-methyl-2-phenoxyquinoxaline 1,4-di-N-oxide (13).  
 
An equimolar amount of phenoxyacetone was added to a solution of the appropriate benzofuroxan 
(3.0-10.0 mmol) in dry dichloromethane (35 mL). The mixture was allowed to stand at 0 ºC. Piperidine 
(1 mL) was added dropwise and the reaction mixture was stirred at room temperature in darkness for 4 
hours. After evaporating to dryness under reduced pressure, a crude solid was obtained, which was 
then washed by adding diethyl ether (or n-hexane), affording the target compound. The precipitate 
obtained was purified by recrystallization from a mixture of methanol/dichloromethane. IR ν/cm-1: 
1326, 1093, 760; 1H-NMR (CDCl3) δ/ppm: 2.72 (s, 3H, C3-CH3), 6.98 (d, J=7.72 Hz, 2H, H2’+H6’), 
7.19 (t, J= 7.42 Hz, 1H, H4’), 7.39 (dd, J=7.57 Hz, 2H, H3’+H5’); 7.87 (m, 2H, H6+H7); 8.63 (m, 1H, 
H5); 8.69 (m, 1H, H8). 
 
Table 1. Structure, analytical data (C, H, N) and MS of the synthesized compounds 
N
+
N
+
O
O
R7
R6
R2
CH3
 
ID R2 R6 R7 Formula MW 
Calc. C 
(found) 
Calc. H 
(found) 
Calc. N 
(found) 
MS (EI, 70 
eV): m/z 
1 CH2-Ph H H C16H14N2O2 266.30 
72.17 
(71.78) 
5.30 
(5.27) 
10.52 
(10.24) 
266 ([M·]+), 249, 
232 
2 CH2-Ph H F C16H13FN2O2 284.29 
67.60 
(67.34) 
4.61 
(4.52) 
9.85 
(10.19) 
284 ([M·]+), 267, 
250 
3 CH2-Ph H Cl C16H13ClN2O2 300.75 
63.90 
(64.01) 
4.36 
(4.30) 
9.31 
(9.42) 
300 ([M·]+), 283, 
266 
4 CH2-Ph H CH3 C17H16N2O2 280.33 
72.84 
(72.45) 
5.75 
(5.66) 
9.99 
(10.30) 
280 ([M·]+), 263, 
246, 230 
5 CH2-Ph H OCH3 C17H16N2O3 296.33 
68.91 
(68.59) 
5.44 
(5.34) 
9.45 
(9.58) 
296 ([M·]+), 279, 
262, 247, 219 
6 CH2-Ph F OCH3 C17H15FN2O3 314.32 
64.96 
(65.01) 
4.81 
(4.83) 
8.91 
(8.69) 
314 ([M·]+), 297, 
280, 265, 237 
7 CH2-Ph F F C16H12F2N2O2 302.28 
63.58 
(63.61) 
4.00 
(3.70) 
9.27 
(9.00) 
302 ([M·]+), 285, 
268 
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Table 1. Cont.  
8 CH2-Ph Cl Cl C16H12Cl2N2O4 335.19 
57.33 
(57.04) 
3.61 
(3.52) 
8.36 
(7.99) 
334 ([M·]+), 317, 
300, 285 
9 CH2-Ph CH3 CH3 C18H18N2O2 294.36 
73.45 
(73.16) 
6.16 
(6.16) 
9.52 
(9.41) 
294 ([M·]+), 277, 
260, 245 
10 NH2 H H C9H9N3O2·H2O 191.19+18.02 
51.67 
(51.61) 
5.30 
(5.52) 
20.09 
(19.77) 
191 ([M·]+), 173, 
145 
11 NH2 H Cl C9H8ClN3O2·½H2O 225.64+9.01 
46.03 
(46.40) 
3.83 
(3.63) 
17.90 
(17.51) 
225 ([M·]+), 208, 
191 
12 NH2 Cl Cl C9H7Cl2N3O2 260.08 
41.56 
(41.90) 
2.71 
(2.72) 
16.16 
(15.78) 
259 ([M·]+), 243, 
226 
13 O-Ph H H C15H12N2O3 268.27 
67.16 
(66.81) 
4.51 
(4.52) 
10.44 
(10.05) 
268 ([M·]+), 251, 
234, 175 
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